perinatologyРоссийский вестник перинатологии и педиатрииRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)1027-40652500-2228Ltd. “The National Academy of Pediatric Science and Innovation”10.21508/1027-4065-2019-64-2-30-37perinatology-853Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWSУвеит, ассоциированный с ювенильным идиопатическим артритомUveitis associated with juvenile idiopathic arthritishttps://orcid.org/0000-0002-5616-3998ГалстянЛ. А.GalstyanL. A.

Галстян Леля Арутюновна – к.м.н., асс. кафедры детских болезней лечебного факультета.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

dr.galstian@mail.ruhttps://orcid.org/0000-0002-2835-2839ЖолобоваЕ. С.ZholobovaE. S.

Жолобова Елена Спартаковна – д.м.н., проф. кафедры детских болезнейлечебного факультета.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

Moscow

https://orcid.org/0000-0001-5669-4214ЧебышеваС. Н.ChebyshevaS. N.

Чебышева Светлана Николаевна – к.м.н., доцент кафедры детских болезней лечебного факультета.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

Moscow

https://orcid.org/0000-0002-4125-0335МелешкинаА. В.MeleshkinaA. V.

Мелешкина Ангелина Валерьевна – к.м.н., доцент кафедры детских болезней лечебного факультета.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

Moscow

https://orcid.org/0000-0001-9186-0126СераяВ. А.SerayaV. A.

Серая Валентина Анатольевна – к.м.н., ассистент кафедры детских болезней лечебного факультета.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

Moscow

https://orcid.org/0000-0002-9059-2745ЛоскутоваО. Ю.LoskutovaO. Yu.

Лоскутова Ольга Юрьевна – к.м.н., врач-ревматолог.

119991 Москва, ул. Трубецкая, д. 8, стр. 2.

Moscow

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияSechenov First Moscow State Medical University (Sechenov University)Russian Federation2019140520196423037Copyright © Ltd. “The National Academy of Pediatric Science and Innovation”, 20192019Ltd. “The National Academy of Pediatric Science and Innovation”Ltd. “The National Academy of Pediatric Science and Innovation”https://www.ped-perinatology.ru/jour/about/submissions#copyrightNoticehttps://www.ped-perinatology.ru/jour/article/view/853

Ревматоидный увеит представляет серьезную проблему в ревматологии и офтальмологии в связи с особенностями заболевания – малозаметным началом, хроническим течением и высокой частотой инвалидизирующих осложнений. В обзоре проанализированы различные сведения о развитии и характере увеита у детей с ювенильным идиопатическим артритом. Приведен анализ результатов широкого спектра исследований этого заболевания. Рассмотрены особенности и результаты лечения детей с ревматоидным увеитом с использованием генно-инженерных биологических препаратов.

Rheumatoid uveitis is a serious problem in rheumatology and ophthalmology due to the peculiarities of the disease – an undistinguished beginning, chronic course and a high incidence of disabling complications. The article analyzes various data on the development and nature of uveitis in children with juvenile idiopathic arthritis. The authors describe the analysis of the results of various studies of this disease. They consider the features and results of treatment of children with rheumatoid uveitis using genetically engineered biological drugs.

детиювенильный идиопатический артритувеитгенно-инженерная биологическая терапияchildrenjuvenile idiopathic arthritisuveitisgenetic engineering biological therapyReferencesHeiligenhaus A., Heinz C., Edelsten C., Kotaniemi K., Minden K. Review for Disease of the Year: Epidemiology of Juvenile Idiopathic Arthritis and its Associated Uveitis: The Probable Risk Factors. Ocular Immunol Inflamm 2013; 21(3): 180–191.DOI: 10.3109/09273948.2013.791701Heiligenhaus A., Heinz C., Edelsten C., Kotaniemi K., Minden K. Review for Disease of the Year: Epidemiology of Juvenile Idiopathic Arthritis and its Associated Uveitis: The Probable Risk Factors. Ocular Immunol Inflamm 2013; 21(3): 180–191.DOI: 10.3109/09273948.2013.791701Carvounis P.E., Herman D.C., Cha S., Burke J.P. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefe’s Arch Clin Exper Ophthalmol 2006; 244: 281–290. DOI: 10.1186/1745-6215-15-14Carvounis P.E., Herman D.C., Cha S., Burke J.P. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefe’s Arch Clin Exper Ophthalmol 2006; 244: 281–290. DOI: 10.1186/1745-6215-15-14Saurenmann R.K., Rose J.B., Tyrrell P., Feldman B.M., Laxer R.M., Schneider R., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis Rheum 2007; 56: 1974–1984. DOI: 10.1002/art.22709Saurenmann R.K., Rose J.B., Tyrrell P., Feldman B.M., Laxer R.M., Schneider R., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis Rheum 2007; 56: 1974–1984. DOI: 10.1002/art.22709Heiligenhaus A., Niewerth M., Ganser G., Heinz C., Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007; 46: 1015–1019. DOI: 10.1093/rheumatology/kem053Heiligenhaus A., Niewerth M., Ganser G., Heinz C., Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007; 46: 1015–1019. DOI: 10.1093/rheumatology/kem053Kotaniemi K., Kautiainen H., Karma A., Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology 2001; 108: 2071–2075. DOI: 10.1016/j.jaapos.2008.03.007Kotaniemi K., Kautiainen H., Karma A., Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology 2001; 108: 2071–2075. DOI: 10.1016/j.jaapos.2008.03.007Brewerton D.A., Caffrey M., Nicholls A., Walters D., James D.C. Acute anterior uveitis and HL-A 27. Lancet 1973; 2: 994–996.Brewerton D.A., Caffrey M., Nicholls A., Walters D., James D.C. Acute anterior uveitis and HL-A 27. Lancet 1973; 2: 994–996.Angeles-Han S.T., McCracken C., Yeh S., Jang S.R., Jenkins K., Cope S. et al. HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis. Investigat Ophthalmol Visual Sci 2015; 56(10): 6043–6048. DOI: 10.1186/s12969-015-0018-8Angeles-Han S.T., McCracken C., Yeh S., Jang S.R., Jenkins K., Cope S. et al. HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis. Investigat Ophthalmol Visual Sci 2015; 56(10): 6043–6048. DOI: 10.1186/s12969-015-0018-8Murray K.J., Moroldo M.B., Donelly P., Prahalad S., Passo M.H., Giannini E.H., Glass D.N. Age-specific effects of juvenile rheumatoid arthritis – associated HLA alleles. Arthritis Rheum 1999; 42: 1843–1853. DOI: 10.1167/iovs.15-17168.Murray K.J., Moroldo M.B., Donelly P., Prahalad S., Passo M.H., Giannini E.H., Glass D.N. Age-specific effects of juvenile rheumatoid arthritis – associated HLA alleles. Arthritis Rheum 1999; 42: 1843–1853. DOI: 10.1167/iovs.15-17168.Жолобова Е.С., Галстян Л.А., Николаева М.Н., Лоскутова О.Ю., Старикова А.В., Денисова Е.В. Эффективность адалимумаба при лечении ювенильного идиопатического артрита с увеитом. Педиатрия. Журнал им. Г.Н. Сперанского 2014; 3: 67–71. DOI: 10.15690/vsp.v14i6.1475Zholobova E.S., Galstyan L.A., Nicolaeva M.N., Loskutova O.Yu., Starikova A.V., Denisova E.V. Efficacy of adalimumab for treatment of juvenile idiopathic arthritis. Pediatria 2014; 3: 67–71. (in Russ) DOI: 10.15690/vsp.v14i6.1475Sen E.S., Dick A.D., Ramanan A.V. Uveitis associated with juvenile idiopathic arthritis. Nature Rev Rheumatol 2015; 11(6): 338–348. DOI: 10.1038/nrrheum.2015.20Sen E.S., Dick A.D., Ramanan A.V. Uveitis associated with juvenile idiopathic arthritis. Nature Rev Rheumatol 2015; 11(6): 338–348. DOI: 10.1038/nrrheum.2015.20Дроздова Е.А., Ядыкина Е.В. Значение интерлейкина-17 в развитии увеита у детей с ювенильным идиопатическим артритом (ЮИА). Вестник Оренбургского государственного университета 2015; 12(187): 64–70.Drozdova E.A., Yadykina E.V. Significance of interleukin-17 in the development of uveitis in children with juvenile idiopathic arthritis (JIA). Vestnik OGU 2015; 12(187): 64–70. (in Russ)Walscheid K., Hennig M., Heinz C., Wasmuth, S., Busch M., Bauer D. et al. Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis associated uveitis. Invest Ophthalmol Vis Sci 2014; 55: 3447–3453. DOI: 10.1167/iovs.13-13444Walscheid K., Hennig M., Heinz C., Wasmuth, S., Busch M., Bauer D. et al. Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis associated uveitis. Invest Ophthalmol Vis Sci 2014; 55: 3447–3453. DOI: 10.1167/iovs.13-13444Deschenes J., Murray P.I., Rao N.A., Nussenblatt R.B. International Uveitis Study Group International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm 2008; 16(1): 1–2. DOI: 10.1080/09273940801899822Deschenes J., Murray P.I., Rao N.A., Nussenblatt R.B. International Uveitis Study Group International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm 2008; 16(1): 1–2. DOI: 10.1080/09273940801899822Clarke S.L., Sen E.S., Ramanan A.V. Juvenile idiopathic arthritis-associated uveitis. Pediatric Rheumatol Online J 2016; 14(27). DOI: 10.1186/s12969-016-0088-2Clarke S.L., Sen E.S., Ramanan A.V. Juvenile idiopathic arthritis-associated uveitis. Pediatric Rheumatol Online J 2016; 14(27). DOI: 10.1186/s12969-016-0088-2Ядыкина Е.В., Дроздова Е.А., Ивановская Е.А. Предрасполагающие факторы риска развития увеита при ювенильном идиопатическом артрите. Медицинский вестник Башкортостана 2014; 2: 190–193.Yadykina E.V., Drozdova E.A., Ivanovskaya E.A. Predisposing risk factors for the development of uveitis related to juvenile idiopathic arthritis. Meditsinskii vestnik Bashkortostana 2014; 2: 190–193. (in Russ)Катаргина Л.А., Архипова Л.Т. Увеиты: патогенетическая иммуносупрессивная терапия. Тверь: Триада, 2004; 100.Katargina L.A., Arhipova L.T. Uveitis: pathogenetic immunosuppressive therapy. Tver’: Triada, 2004; 100. (in Russ)British Society for Paediatric and Adolescent Rheumatology, Royal College of Ophthalmology. Guidelines for screening for Uveitis in Juvenile idiopathic arthritis. 2006; 55: 373–377. DOI: 10.118/sl12969-017-0185-xBritish Society for Paediatric and Adolescent Rheumatology, Royal College of Ophthalmology. Guidelines for screening for Uveitis in Juvenile idiopathic arthritis. 2006; 55: 373–377. DOI: 10.118/sl12969-017-0185-xJabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140(3): 509–516. DOI: 10.1056/NEJMc1603618Jabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140(3): 509–516. DOI: 10.1056/NEJMc1603618Tappeiner C., Heinz C., Roesel M., Heiligenhaus A. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol 2011; 89(6): 521–527. DOI: 10.1111/j.1755-3768.Tappeiner C., Heinz C., Roesel M., Heiligenhaus A. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol 2011; 89(6): 521–527. DOI: 10.1111/j.1755-3768.Holland G.N. A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2007; 105: 344–364.Holland G.N. A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2007; 105: 344–364.Heinz C., Schumacher C., Roesel M., Heiligenhaus A. Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity. Brit J Ophthalmol 2012; 96: 140–141. DOI: 10.1136/bjophthalmol-2011-300731Heinz C., Schumacher C., Roesel M., Heiligenhaus A. Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity. Brit J Ophthalmol 2012; 96: 140–141. DOI: 10.1136/bjophthalmol-2011-300731Ducos de Lahitte G., Terrada C., Tran T., Cassoux N., Le Hoang P., Kodjikian L. et al. Maculopathy in uveitis of juvenile idiopathic arthritis: coherence tomography study. Brit J Ophthalmol 2008; 92(8): 1159. DOI: 10.1136/bjo.2007.120675Ducos de Lahitte G., Terrada C., Tran T., Cassoux N., Le Hoang P., Kodjikian L. et al. Maculopathy in uveitis of juvenile idiopathic arthritis: coherence tomography study. Brit J Ophthalmol 2008; 92(8): 1159. DOI: 10.1136/bjo.2007.120675Hawkins M.J., Dick A.D., Lee R.J., Ramanan A.V., Carreño E., Guly C.M. et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol 2016; 61(2): 197–210. DOI: 10.1016/j.survophthal.2015.10.005Hawkins M.J., Dick A.D., Lee R.J., Ramanan A.V., Carreño E., Guly C.M. et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol 2016; 61(2): 197–210. DOI: 10.1016/j.survophthal.2015.10.005Ревматология. Национальное руководство. Под редакцией Е.Л. Насонова, В.А. Насоновой. Москва: ГЭОТАР-Медиа, 2008; 720.Rheumatology. E.L. Nasonov, V.A. Nasonova (eds). Moscow: GEOTAR-Media, 2008; 720. (in Russ)Hoeve M., Kalinina Ayuso V., Schalij-Delfos N.E., Los L.I., Rothova A., de Boer J.H. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Brit J Ophthalmol 2012; 96: 852–856. DOI: 10.1371/journal.pone.0164312Hoeve M., Kalinina Ayuso V., Schalij-Delfos N.E., Los L.I., Rothova A., de Boer J.H. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Brit J Ophthalmol 2012; 96: 852–856. DOI: 10.1371/journal.pone.0164312Дроздова Е.А., Ядыкина Е.В. Клинические параллели течения увеита и артрита у пациентов с ювенильным идиопатическим артритом. Вестник СМУ 2014; 1–2: 41–44.Drozdova E.A., Yadykina E.V. Clinical parallels of uveitis and arthritis course in patients with juvenile idiopathic arthritis. Vestnik SMU 2014; 1–2: 41–44. (in Russ)Davies K., Cleary G., Foster H., Hutchinson E., Baildam E. British Society of Paediatric and Adolescent Rheumatology BSPAR standards of care for children and young people with juvenile idiopathic arthritis. Rheumatology 2010; 49(7): 1406–1408. DOI: 10.1186/s12969-017-0170-4Davies K., Cleary G., Foster H., Hutchinson E., Baildam E. British Society of Paediatric and Adolescent Rheumatology BSPAR standards of care for children and young people with juvenile idiopathic arthritis. Rheumatology 2010; 49(7): 1406–1408. DOI: 10.1186/s12969-017-0170-4Merida S., Palacios E., Navea A. New Immunosuppressive Therapies in Uveitis Treatment. Int J Mol Sci 2015; 16(8): 18778–18795. DOI: 10.3390/ijms160818778Merida S., Palacios E., Navea A. New Immunosuppressive Therapies in Uveitis Treatment. Int J Mol Sci 2015; 16(8): 18778–18795. DOI: 10.3390/ijms160818778La Mattina K.C., Goldstein D.A. Adalimumab for the treatment of uveitis. Expert Rev Clin Immunol 2017; 13(3): 181–188. DOI: 10.1080/1744666X.2017.1288097La Mattina K.C., Goldstein D.A. Adalimumab for the treatment of uveitis. Expert Rev Clin Immunol 2017; 13(3): 181–188. DOI: 10.1080/1744666X.2017.1288097Vazquez-Cobian L.B., Flynn T., Lehman T.J. Adalimumab therapy for childhood uveitis. J Pediatr 2006; 149(4): 572–575. DOI: 10.1016/j.jpeds.2006.04.058Vazquez-Cobian L.B., Flynn T., Lehman T.J. Adalimumab therapy for childhood uveitis. J Pediatr 2006; 149(4): 572–575. DOI: 10.1016/j.jpeds.2006.04.058Biester S., Deuter C., Michels H., Haefner R., Kuemmerle-Deschner J., Doycheva D. et al. Adalimumab in the therapy of uveitis in childhood. Brit J Ophthalmol 2007; 91: 319–324. DOI: 10.1136/bjo.2006.103721Biester S., Deuter C., Michels H., Haefner R., Kuemmerle-Deschner J., Doycheva D. et al. Adalimumab in the therapy of uveitis in childhood. Brit J Ophthalmol 2007; 91: 319–324. DOI: 10.1136/bjo.2006.103721Ramanan A.V., Dick A.D., McKay A., Jones A., Williamson P., Compeyrot-Lacassagne S. et al. A randomized controlled trial of the clinical effectiviness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis. Arthritis Rheum 2015; 67(10). DOI: 10.1186/s12969-016-0088-2Ramanan A.V., Dick A.D., McKay A., Jones A., Williamson P., Compeyrot-Lacassagne S. et al. A randomized controlled trial of the clinical effectiviness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis. Arthritis Rheum 2015; 67(10). DOI: 10.1186/s12969-016-0088-2Алексеева Е.И., Митенко Е.В., Валиева С.И., Бзарова Т.М., Денисова Р.В., Исаева К.Б. и др. Эффективность и безопасность терапии адалимумабом у детей с ювенильным идиопатическим артритом и увеитом. Вопросы современной педиатрии 2012; 1: 111–118. DOI: 10.15690/vsp.v11i1.141Alekseeva E.I., Mitenko E.V., Valieva S.I., Bzarova T.M., Denisova R.V., Isaeva K.B. et al. Efficacy and safety of pediatric juvenile idiopathic arthritis and uveitis treatment with adalimumab. Voprosy sovremennoi pediatrii 2012; 1: 111–118. (in Russ) DOI: 10.15690/vsp.v11i1.141Кельцев В.А., Гребенкина Л.И., Моисеева Е.Д. Сравнительная оценка эффективности и безопасности лечения адалимумабом в комбинации с метотрексатом и монотерапии метотрексатом у детей с полиартикулярным ювенильным идиопатическим артритом в сочетании с увеитом. Вопросы современной педиатрии 2014; 6: 60–66. DOI: 10.15690/vsp.v14i6.1475Kel’cev V.A., Grebyonkina L.I., Moiseeva E.D. Comparative evaluation of the efficacy and safety of treatment using adalimumab in combination with methotrexate and methotrexate monotherapy in children with polyarticular juvenile idiopathic arthritis in combination with uveitis. Voprosy sovremennoi pediatrii 2014; 6: 60–66. (in Russ) DOI: 10.15690/vsp.v14i6.1475Гайдар Е.В., Костик М.М., Дубко М.Ф., Масалова В.В., Снегирева Л.С., Исупова Е.А. и др. Эффективность адалимумаба при хроническом переднем увеите, ассоциированном с ювенильным идиопатическим артритом и резистентным к терапии метотрексатом: ретроспективное исследование серии случаев. Педиатрическая фармакология 2016; 4: 340–344. DOI: 10.15690/pf.v13i4.1605Gajdar E.V., Kostik M.M., Dubko M.F., Masalova V.V., Snegireva L.S., Isupova E.A. et al. The Efficiency of Adalimumab in Cases of Chronic Methotrexate-Resistant Juvenile Idiopathic Arthritis-Associated Anterior Uveitis: Retrospective Case Series Study. Pediatricheskaya farmakologiya 2016; 4: 340–344. (in Russ) DOI: 10.15690/pf.v13i4.1605Павхун Т.В., Шишкина И.К., Пищулина И.В., Юсупова М.Х., Горшкова Л.В. Эффективность применения ингибитора TNF-α адалимумаба у пациентки с хроническим увеитом в дебюте ювенильного идиопатического артрита. Педиатрическая фармакология 2016; 1: 54–58. DOI: 10.15690/pf.v13i1.1516PavhunT.V., Shishkina I.K., Pishchulina I.V., Yusupova M.K., Gorshkova L.V. Efficacy of use TNF-α inhibitor adalimumab in a female patient with chronic uveitis in the onset of juvenile idiopathic arthritis. Pediatricheskaya farmakologiya 2016; 1: 54–58. (in Russ) DOI: 10.15690/pf.v13i1.1516Исаева К.Б., Алексеева Е.И., Денисова Р.В., Слепцова Т.В., Бзарова Т.М., Валиева С.И. и др. Опыт применения адалимумаба у пациентки с ранним дебютом ювенильного идиопатического артрита и увеитом. Вопросы современной педиатрии 2014; 4: 156–161.Isaeva K.B., Alekseeva E.I., Denisova R.V., Sleptsova T.V., Bzarova Т.М., Valieva S.I. et al. Experience of the adalimumab application for the patient with early debut of juvenile idiopathic arthritis and uveitis. Voprosy sovremennoi pediatrii 2014; 4: 156–161. (in Russ)Kahn P., Weiss M., Imundo L., Levy D.M. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006; 113: 860–864. DOI: 10.5402/2012/765380Kahn P., Weiss M., Imundo L., Levy D.M. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006; 113: 860–864. DOI: 10.5402/2012/765380Ayranci O., Tugal-Tutkun I., Kasapcopur O. Infliximab treatment for refractory childhood uveitis. 9th International Congress IOIS, 2007; OP10-05. DOI: 10.4274/tjo.09581Ayranci O., Tugal-Tutkun I., Kasapcopur O. Infliximab treatment for refractory childhood uveitis. 9th International Congress IOIS, 2007; OP10-05. DOI: 10.4274/tjo.09581Нероев В.В., Катаргина Л.А., Денисова Е.В., Старикова А.В., Любимова Н.В. Эффективность генно-инженерных биологических препаратов в лечении увеитов, ассоциированных с ревматическими заболеваниями у детей. Научно-практическая ревматология 2012; 4(53): 91–95.Neroev V.V., Katargina L.A., Denisova E.V., Starikova A.V., Lyubimova N.V. Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children. Nauchno-prakticheskaya revmatologiya 2012; 4(53): 91–95. (in Russ)Zannin M.E., Birolo C., Gerloni V., Miserocchi E., Pontikaki I., Paroli M.P. et al. Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry. J Rheumatol 2013; 40(1): 74–79. DOI: 10.3899/jrheum.120583Zannin M.E., Birolo C., Gerloni V., Miserocchi E., Pontikaki I., Paroli M.P. et al. Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry. J Rheumatol 2013; 40(1): 74–79. DOI: 10.3899/jrheum.120583Smith J.A., Thompson D.J., Whitcup S.M., Suhler E., Clarke G., Smith S. et al. A randomized, placebo-controlled, doublemasked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Care Res 2005; 53: 18–23. DOI: 10.1002/art.20904Smith J.A., Thompson D.J., Whitcup S.M., Suhler E., Clarke G., Smith S. et al. A randomized, placebo-controlled, doublemasked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Care Res 2005; 53: 18–23. DOI: 10.1002/art.20904Kakkassery V., Mergler S., Pleyer U. Anti-TNF-alpha Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment. Curr Eye Res 2010; 35: 751–756. DOI: 10.3109/02713683.2010.486520Kakkassery V., Mergler S., Pleyer U. Anti-TNF-alpha Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment. Curr Eye Res 2010; 35: 751–756. DOI: 10.3109/02713683.2010.486520Schmeling H., Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 2005; 44: 1008–1011. DOI: 10.1093/rheumatology/keh658Schmeling H., Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 2005; 44: 1008–1011. DOI: 10.1093/rheumatology/keh658Foeldvari I., Becker I., Horneff G. Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry. Arthritis Care Res 2015; 67(11): 1529–1535. DOI: 10.1002/acr.22613Foeldvari I., Becker I., Horneff G. Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry. Arthritis Care Res 2015; 67(11): 1529–1535. DOI: 10.1002/acr.22613Angeles-Han S., Flynn T., Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis. A case report. J Rheumatol 2008; 35(9): 1897–1898. DOI: 10.1007/s40674-017-0057-zAngeles-Han S., Flynn T., Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis. A case report. J Rheumatol 2008; 35(9): 1897–1898. DOI: 10.1007/s40674-017-0057-zElhai M., Deslandre C.J., Kahan A. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases. Comment on the article by Zulian et al. Arthritis Care Res 2011; 63: 307–308. DOI: 10.1002/acr.20359Elhai M., Deslandre C.J., Kahan A. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases. Comment on the article by Zulian et al. Arthritis Care Res 2011; 63: 307–308. DOI: 10.1002/acr.20359Alpigiani M.G., Salvati P., Vannati M., Bagnis A., Papadia M., Traverso C.E. et al. Abatacept for severe anti TNF-alpha refractory JIA-associated uveitis: a case report. Clin Exp Rheumatol 2011; 29: 410. DOI: 10.1016/j.semarthrit.2015.05.010Alpigiani M.G., Salvati P., Vannati M., Bagnis A., Papadia M., Traverso C.E. et al. Abatacept for severe anti TNF-alpha refractory JIA-associated uveitis: a case report. Clin Exp Rheumatol 2011; 29: 410. DOI: 10.1016/j.semarthrit.2015.05.010Zulian F., Balzarin M., Falcini F., Martini G., Alessio M., Cimaz R. et al. Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis. Arthritis Care Res 2010; 62: 821–825. DOI: 10.1002/acr.20115Zulian F., Balzarin M., Falcini F., Martini G., Alessio M., Cimaz R. et al. Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis. Arthritis Care Res 2010; 62: 821–825. DOI: 10.1002/acr.20115Tappeiner C., Miserocchi E., Bodaghi B., Kotaniemi K., Mackensen F., Gerloni V. et al. Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. J Rheumatol 2015; 42(4): 706–711. DOI: 10.3899/jrheum.140410Tappeiner C., Miserocchi E., Bodaghi B., Kotaniemi K., Mackensen F., Gerloni V. et al. Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. J Rheumatol 2015; 42(4): 706–711. DOI: 10.3899/jrheum.140410Галстян Л.А., Жолобова Е.С., Старикова А.В., Денисова Е.В. Эффективность терапии абатацептом у пациентки с ювенильным идиопатическим артритом и двухсторонним увеитом. Вопросы cовременной педиатрии 2016; 3: 307–310. DOI: 10.15690/vsp.v15i3.1569Galstyan L.A., Zholobova E.S., Starikova A.V., Denisova E.V. Efficacy of abatacept therapy in a patient with juvenile idiopathic arthritis and bilateral uveitis. Voprosy sovremennoi pediatrii 2016; 3: 307–310. (in Russ) DOI: 10.15690/vsp.v15i3.1569Tappeiner C., Mesquida M., Adan A., Anton J., Ramanan A.V., Carreno E. et al. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. J Rheumatol 2016, 43(12): 2183–2188. DOI: 10.3899/jrheum.160231Tappeiner C., Mesquida M., Adan A., Anton J., Ramanan A.V., Carreno E. et al. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. J Rheumatol 2016, 43(12): 2183–2188. DOI: 10.3899/jrheum.160231Bou R., Adan A., Borras F., Bravo B., Calvo I., De Inocencioet J. et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int 2015; 35(5): 777–785. DOI: 10.1007/s00296-015-3231-3Bou R., Adan A., Borras F., Bravo B., Calvo I., De Inocencioet J. et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int 2015; 35(5): 777–785. DOI: 10.1007/s00296-015-3231-3Lerman M.A., Lewen M.D., Kempen J.H., Monte D.M. Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 2015; 160(1): 193–200. DOI: 10.1016/j.ajo.2015.04.016Lerman M.A., Lewen M.D., Kempen J.H., Monte D.M. Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 2015; 160(1): 193–200. DOI: 10.1016/j.ajo.2015.04.016Heiligenhaus A., Miserocchi E., Heinz C., Gerloni V., Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford) 2011; 50: 1390–1394. DOI: 10.4274/tjo.09581Heiligenhaus A., Miserocchi E., Heinz C., Gerloni V., Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford) 2011; 50: 1390–1394. DOI: 10.4274/tjo.09581Sen H.N., Levy-Clarke G., Faia L.J., Li Z., Yeh S., Barron K.S. et al. High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol 2009; 148: 696–703. DOI: 10.1016/j.ajo.2009.06.003Sen H.N., Levy-Clarke G., Faia L.J., Li Z., Yeh S., Barron K.S. et al. High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol 2009; 148: 696–703. DOI: 10.1016/j.ajo.2009.06.003Hayward K., Wallace C.A. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res& Therapy 2009; 11: 216. DOI: 10.1186/ar2619Hayward K., Wallace C.A. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res& Therapy 2009; 11: 216. DOI: 10.1186/ar2619Салугина С.О., Катаргина Л.А., Старикова А.В. Ревматические заболевания и поражение глаз у детей. Научно-практическая ревматология 2004; 42(1): 78–81. DOI: 10.14412/1995-4484-2004-1389Salugina S.О., Katargina L.A., Starikova A.V. Rheumatological diseases and eyes lesions in children. Nauchno-prakticheskaya revmatologiya 2004; 42(1): 78–81. (in Russ) DOI: 10.14412/1995-4484-2004-1389

The authors declare that there are no conflicts of interest present.